Musculoskeletal

Pseudogout (CPPD): diagnosis and management

Clinical Overview and When to Suspect Pseudogout (CPPD)

— Acute monoarthritis in an elderly patient, especially the knee (50%) or wrist (second most common)

— Subacute polyarticular flare resembling RA in a patient over 60 with normal RF/CCP

— "Gout in atypical joints" — wrists, MCPs, shoulders, elbows

— Flare precipitated by hospitalization, surgery, trauma, or acute medical illness (classic inpatient consult scenario)

— Incidental chondrocalcinosis seen on a knee or wrist X-ray

Board pearl: New CPPD in a patient under age 55 mandates a metabolic workup — check calcium, PTH, magnesium, phosphate, alkaline phosphatase, ferritin, iron studies, and TSH. Missing hemochromatosis or primary hyperparathyroidism in a young "pseudogout" patient is a frequent vignette trap.

Calcium pyrophosphate deposition disease (CPPD) is a crystal arthropathy caused by deposition of calcium pyrophosphate dihydrate crystals in articular and periarticular tissues, producing a spectrum from asymptomatic chondrocalcinosis to acute "pseudogout" flares and chronic CPP arthritis.

Epidemiology favors older adults: prevalence rises sharply after age 60, affecting ~10–15% of those 65–75 and up to 30–50% of octogenarians on imaging surveys.

When to suspect in a Family Medicine clinic:

Provocative associations to screen for (the "4 H's plus"): Hyperparathyroidism, Hemochromatosis, Hypophosphatasia, Hypomagnesemia, and hypothyroidism; also Wilson disease, gout coexistence, and Gitelman syndrome.

Step 3 framing: CPPD is a longitudinal outpatient diagnosis with episodic acute management — the boards reward recognizing secondary causes and avoiding overtreatment of asymptomatic chondrocalcinosis.

Terminology update (2023 ACR/EULAR): "acute CPP crystal arthritis" replaces "pseudogout"; "chronic CPP crystal inflammatory arthritis" replaces "pseudo-RA." Recognize both old and new nomenclature on exams.

Presentation Patterns and Key History

— Asymptomatic chondrocalcinosis: incidental radiographic calcification, no symptoms; no treatment needed.

— Acute CPP crystal arthritis (pseudogout): abrupt mono/oligoarticular swelling, warmth, erythema, peaking in 6–24 hours; lasts days to 2 weeks; self-limited.

— Chronic CPP inflammatory arthritis (pseudo-RA): symmetric polyarthritis with prolonged morning stiffness, low-grade synovitis — mimics RA but RF/anti-CCP negative.

— Osteoarthritis with CPPD (pseudo-OA): degenerative joint disease in atypical OA sites (wrist MCP, glenohumeral), often with superimposed flares.

— Crowned dens syndrome: CPPD around the odontoid → acute neck pain, fever, elevated CRP → mimics meningitis or giant cell arteritis.

— Spinal CPPD: can mimic discitis or spinal stenosis.

— Joint involvement pattern, time-to-peak (rapid = crystal disease)

— Triggers: recent surgery (especially parathyroidectomy), IV bisphosphonate, hospitalization, trauma, intra-articular hyaluronate, severe medical illness

— Prior similar episodes in same or different joints

— Family history (autosomal dominant familial CPPD — ANKH gene mutations, early onset)

— Diet/alcohol (less relevant than gout, but rule out coexisting gout)

— Medications: loop diuretics, PPIs (hypomagnesemia)

Key distinction: Gout peaks in hours and classically targets the 1st MTP in middle-aged men; pseudogout peaks over a day and targets the knee/wrist in older patients. Both can coexist ("mixed crystal arthropathy") — never assume one excludes the other without arthrocentesis.

CPPD has six classic clinical phenotypes — the vignette will hint at one:

Key history elements to elicit:

Functional impact: ask about ADLs, fall risk, driving, work — critical for the outpatient management decisions Step 3 loves.

Red-flag overlay: fever + monoarthritis still demands ruling out septic arthritis even with known CPPD — crystals and infection can co-occur.

Physical Exam Findings

— Monoarticular swelling with tense effusion, erythema, warmth, severe pain on passive ROM

— Knee most common: large effusion, positive bulge sign, ballottable patella, flexion contracture from guarding

— Wrist: dorsal swelling, restricted dorsiflexion, tenderness over radiocarpal joint

— Shoulder/elbow involvement should raise CPPD suspicion in elderly

— Skin: erythema can extend beyond joint, mimicking cellulitis — palpate for fluctuance and assess lymphatic streaking (absent in crystal arthritis)

— Symmetric synovitis of MCPs, wrists, knees with bony enlargement (vs. soft synovial proliferation of RA)

— Less prominent MCP squeeze tenderness than RA

— Hook-like osteophytes palpable at MCP heads

— Crepitus, varus/valgus deformity at knee, decreased ROM

— Atypical OA distribution (radiocarpal, glenohumeral, ankle, elbow) is the tipoff

— Severe neck rigidity, fever, occipital headache, limited rotation

— Easily misdiagnosed as meningitis or polymyalgia rheumatica/GCA

— Vitals: low-grade fever common (up to 38.5°C) in acute flare; high fever → think septic arthritis

— Check other joints — polyarticular involvement occurs in 10–20%

— Search for secondary cause clues: skin hyperpigmentation/hepatomegaly (hemochromatosis), neck mass or band keratopathy (hyperparathyroidism), proximal myopathy (hypothyroidism)

Step 3 management: A hot, swollen knee with fever in an 80-year-old post-hip-surgery patient → arthrocentesis before empiric therapy. Document neurovascular exam, mark joint margins, and obtain synovial fluid for cell count, Gram stain, culture, and crystal analysis under polarized light — do not start steroids until septic arthritis is excluded.

Acute CPP arthritis exam:

Chronic CPP inflammatory arthritis exam:

Pseudo-OA exam:

Crowned dens syndrome:

General assessment:

Functional exam: gait, transfers, single-leg stance — informs PT referral and fall-prevention counseling at follow-up.

Diagnostic Workup — Initial Labs and Imaging

— Appearance: cloudy, yellow; viscosity reduced

— WBC 10,000–50,000/µL (inflammatory range); >50,000 raises septic concern but overlaps with crystal flares

— Neutrophil predominance (>75%)

— Gram stain and bacterial culture — always

— Polarized light microscopy: CPP crystals are rhomboid or rod-shaped, weakly positively birefringent (blue when parallel to compensator axis)

— CBC, CMP, CRP/ESR (elevated in flare)

— Metabolic screen for secondary CPPD: calcium, ionized Ca, PTH, magnesium, phosphate, alkaline phosphatase, ferritin, transferrin saturation, TSH

— Uric acid (to evaluate coexistent gout)

— Blood cultures if febrile

— Chondrocalcinosis: linear or punctate calcifications in hyaline cartilage and fibrocartilage — knee menisci, triangular fibrocartilage of wrist, symphysis pubis, glenoid/acetabular labra

— Subchondral cysts, hook osteophytes at MCPs (especially 2nd/3rd), scapholunate advanced collapse (SLAC) wrist

— Absence of chondrocalcinosis does not rule out CPPD (sensitivity ~40%)

Board pearl: Crystals are weakly positively birefringent in CPPD (think "P"seudogout = "P"ositive) versus strongly negatively birefringent needle-shaped monosodium urate crystals in gout. Mnemonic: "Parallel = Blue = Pseudogout (Positive)."

Synovial fluid analysis is the gold standard — arthrocentesis is essential for any acute monoarthritis:

Serum labs:

Plain radiographs of involved joint plus contralateral:

ECG generally not required unless considering colchicine in a patient with QT-prolonging meds or evaluating chest pain mimics.

Sampling tips: even small "dry tap" volumes can yield crystals — send any fluid recovered. If first tap negative but suspicion high, repeat or consider ultrasound-guided aspiration of a deeper effusion.

Diagnostic Workup — Advanced or Confirmatory Studies

— Hyperechoic deposits within hyaline cartilage (thin parallel band, distinct from the "double contour" sign of gout which sits on cartilage surface)

— Fibrocartilage deposits (menisci, TFCC)

— Synovial hypertrophy, power Doppler signal in active flare

— Sensitivity ~80–90%, specificity >90% for CPPD in expert hands

— Established for gout (urate color-coding); emerging for CPPD but not standard — do not pick DECT as the confirmatory test for CPPD on exams.

— CT cervical spine for suspected crowned dens syndrome → calcifications surrounding the odontoid process

— MRI for spinal CPPD or when ruling out discitis, septic facet joint

— Entry: ≥1 episode of joint pain/swelling

— Exclusion: alternative cause more likely

— Weighted items: identification of CPP crystals (sufficient alone), imaging evidence of CPP deposition, typical clinical phenotype, associated metabolic disease, older age

— Elevated PTH + hypercalcemia → primary hyperparathyroidism; obtain neck ultrasound and sestamibi scan, refer endocrine surgery

— Elevated transferrin saturation (>45%) and ferritin → HFE gene testing for hereditary hemochromatosis

— Low alkaline phosphatase → hypophosphatasia (check pyridoxal-5-phosphate)

— Low magnesium → review diuretics, PPIs, malabsorption

Key distinction: Ultrasound "double contour sign" along cartilage surface = urate (gout). Hyperechoic band within the cartilage midsubstance = CPP crystals (pseudogout). Boards love this sonographic dichotomy.

Musculoskeletal ultrasound (increasingly first-line in rheumatology clinics):

Dual-energy CT (DECT):

Advanced imaging for specific phenotypes:

2023 ACR/EULAR classification criteria (for research, but board-friendly framework):

Secondary cause confirmation:

Genetic testing (ANKH, TNFRSF11B) is reserved for early-onset familial cases — not routine.

Risk Stratification and First-Line Management Logic

— Asymptomatic chondrocalcinosis → no pharmacotherapy; reassurance, treat underlying metabolic cause if present

— Acute CPP arthritis → anti-inflammatory therapy + joint aspiration

— Chronic CPP inflammatory arthritis → maintenance immunomodulation

— Pseudo-OA → standard OA management plus flare prophylaxis

— 1–2 accessible joints, no contraindication → intra-articular glucocorticoid injection after aspiration (first-line in elderly)

— Polyarticular or inaccessible joint → systemic therapy: oral NSAID, oral colchicine, or oral/IM glucocorticoid

— Severe polyarticular flare with comorbidity-limited drug options → low-dose prednisone (30–40 mg taper over 1–2 weeks)

— Renal function (eGFR) — limits NSAIDs and colchicine

— Heart failure, hypertension, CAD — limits NSAIDs

— Diabetes, glaucoma, osteoporosis — caution with systemic steroids

— Anticoagulation — favor oral therapy over injection if INR supratherapeutic

— Drug interactions: colchicine + CYP3A4/P-gp inhibitors (clarithromycin, diltiazem, statins) → toxicity risk

— Rest, ice to involved joint, temporary assistive device (cane, walker)

— Acetaminophen up to 3 g/day for breakthrough pain

— Address triggers: hold IV bisphosphonates, optimize magnesium, evaluate recent procedures

Step 3 management: For an 82-year-old with CKD stage 3, HF, and an acutely swollen knee, the safest first-line choice is arthrocentesis with intra-articular triamcinolone 40 mg after septic arthritis is excluded — avoiding both NSAID and colchicine risks. This is a high-yield outpatient decision.

Treatment is phenotype-driven — match therapy to clinical pattern:

Acute flare decision tree (number of joints + comorbidities):

Comorbidity screen before pharmacotherapy:

Non-pharmacologic adjuncts for every flare:

Document shared decision-making — Step 3 vignettes increasingly reward this.

Pharmacotherapy — First-Line Drug Regimens

— Naproxen 500 mg PO BID, indomethacin 50 mg TID, or ibuprofen 800 mg TID for 5–7 days

— Co-prescribe PPI if age >65 or prior PUD

— Contraindications: eGFR <30, active GI bleed, CHF NYHA III–IV, recent MI/CABG, uncontrolled HTN, anticoagulation

— Acute flare: 1.2 mg PO once, then 0.6 mg one hour later, then 0.6 mg BID until resolution (max ~5–7 days)

— Prophylaxis (recurrent flares): 0.6 mg once or twice daily

— Renal dosing: reduce by 50% if CrCl 30–60; avoid or markedly reduce if CrCl <30 or on dialysis

— Hepatic impairment: avoid in severe; reduce dose moderate

— Drug interactions: clarithromycin, erythromycin, diltiazem, verapamil, cyclosporine, ritonavir, strong CYP3A4/P-gp inhibitors → risk of fatal toxicity (pancytopenia, neuromyopathy, rhabdomyolysis)

— Intra-articular triamcinolone 20–40 mg (knee), 10–20 mg (smaller joints) — first-line in elderly/multimorbid

— Oral prednisone 30–40 mg daily × 5 days then taper over 7–10 days

— IM methylprednisolone 80–120 mg when oral not tolerated

— Watch: hyperglycemia (check fingersticks in diabetics), BP, fluid retention, mood, sleep

— Anakinra 100 mg SC daily × 3 days is increasingly used in hospitalized elderly with multiple flares

— Canakinumab for chronic refractory disease (off-label, expensive)

— Low-dose colchicine 0.6 mg BID + low-dose prednisone (≤7.5 mg)

— Methotrexate or hydroxychloroquine for steroid-sparing maintenance (evidence modest but board-acceptable)

Board pearl: Concomitant clarithromycin + colchicine in a patient with CKD is a classic Step 3 prescribing-error vignette → can cause fatal multiorgan toxicity. Switch to azithromycin or hold colchicine.

NSAIDs (preferred in younger, healthier patients):

Colchicine:

Glucocorticoids:

IL-1 blockade (refractory/contraindicated cases):

Chronic CPP inflammatory arthritis:

Always reconcile medications and counsel on stopping colchicine if diarrhea, myalgias, or weakness develops.

Procedures and Expanded Therapeutic Management

— Indications: any acute monoarthritis, suspected septic joint, large symptomatic effusion, planned intra-articular injection

— Technique pearls: aseptic prep, mark landmarks, use 18–20 gauge needle for knee aspiration, send fluid for cell count + diff, Gram stain, culture, and polarized microscopy with crystal analysis

— Aspiration alone reduces intra-articular pressure and crystal load — often produces symptomatic relief even before injection

— Complications: <1% infection, bleeding, post-injection flare (steroid crystal arthritis 1–2%), tendon rupture if peritendinous injection

— Triamcinolone acetonide 40 mg knee, 20 mg wrist/ankle, 10 mg small joints

— Maximum frequency: every 3 months per joint; lifetime caution beyond 3–4 injections per joint

— Hold injection if cellulitis overlies the joint or bacteremia suspected

— Refractory destructive arthropathy → orthopedic referral for arthroplasty (knee, hip, shoulder)

— Crowned dens syndrome rarely requires surgery — responds to NSAIDs/steroids/colchicine

— Tophaceous CPPD masses (rare) may need excision

— Magnesium supplementation if hypomagnesemic — may reduce flare frequency

— Treat hyperparathyroidism — but flares may paradoxically increase in the months after parathyroidectomy; warn patient and pretreat with colchicine prophylaxis

— Phlebotomy for hemochromatosis does not reverse established CPPD but is indicated for iron overload itself

CCS pearl: When ordering for an inpatient pseudogout consult, sequence: arthrocentesis → synovial fluid analysis → empiric ice/acetaminophen → intra-articular triamcinolone after septic arthritis excluded → DC patient with rheumatology and PCP follow-up within 1–2 weeks. Advance clock incrementally and reassess.

Arthrocentesis is both diagnostic and therapeutic:

Intra-articular corticosteroid injection:

Joint lavage/tidal irrigation: limited evidence; not standard.

Surgical considerations:

Disease-modifying attempts (limited evidence base):

Emerging therapies: methotrexate, hydroxychloroquine, tocilizumab, and IL-1 inhibitors for refractory chronic disease — generally rheumatology-directed.

Document procedural consent including risk of infection, bleeding, and post-injection flare.

Special Populations — Elderly and Renal/Hepatic Impairment

— Intra-articular glucocorticoid is first-line for accessible joints due to systemic safety

— Avoid systemic NSAIDs when possible (GI bleed, renal injury, HF exacerbation, drug interactions with anticoagulants)

— Colchicine: start at 0.3–0.6 mg daily; monitor for diarrhea, myopathy, cytopenias

— Systemic steroids: monitor glucose, blood pressure, delirium risk, infection, bone health

— Polypharmacy review — STOPP/Beers criteria

— Fall-prevention assessment after a knee flare (gait, vision, orthostatic vitals, footwear)

— eGFR <60 → avoid chronic NSAIDs; short-course acceptable if eGFR 30–59 with caution

— eGFR <30 → no NSAIDs, no colchicine (or markedly reduced); intra-articular or systemic steroids preferred

— Anakinra is renally cleared — extend dosing interval if eGFR <30

— Adjust gabapentin, opioids, and other adjunctive agents accordingly

— Avoid colchicine in severe hepatic dysfunction (Child-Pugh C)

— NSAIDs increase variceal bleed and hepatorenal risk in cirrhosis — avoid

— Steroids preferred; monitor for hyperglycemia and infection

— Anticipate glucose elevation 2–7 days after intra-articular or systemic steroid

— Counsel to monitor BG more frequently; may need transient insulin adjustment

— Document this conversation

— NSAIDs precipitate decompensation — avoid

— Steroids cause sodium retention — short course usually tolerated; daily weights

— Therapeutic INR/DOAC is not an absolute contraindication to arthrocentesis; small-gauge needle, hold pressure 5–10 minutes

— Avoid NSAIDs entirely with concurrent anticoagulation

Step 3 management: In a 78-year-old on warfarin with INR 2.4 and an acutely swollen knee, proceed with arthrocentesis rather than withholding anticoagulation — diagnostic yield outweighs bleed risk.

Elderly (the modal CPPD patient):

Chronic kidney disease:

Hepatic impairment:

Diabetes mellitus:

Heart failure:

Anticoagulation:

Special Populations — Pregnancy, Pediatrics, and Familial CPPD

— CPPD is extremely rare in reproductive-age women — its presence should prompt evaluation for secondary metabolic disease (hyperparathyroidism, hypomagnesemia, hypophosphatasia)

— NSAIDs: avoid after 20 weeks (oligohydramnios) and after 30 weeks (premature ductus closure)

— Colchicine: pregnancy category historically C; data from FMF cohorts reassuring — generally considered acceptable when benefit outweighs risk

— Intra-articular corticosteroid injection is preferred for localized flares

— Coordinate with maternal-fetal medicine

— CPPD in children/adolescents is pathognomonic for a familial or metabolic cause until proven otherwise

— Evaluate for: familial chondrocalcinosis (ANKH mutations, autosomal dominant), hypophosphatasia (low alkaline phosphatase), hypomagnesemia (Gitelman, Bartter), Wilson disease

— Refer to pediatric rheumatology and genetics

— Two known loci: CCAL1 (5p15, TNFRSF11B) and CCAL2 (5p — ANKH gene)

— Early-onset (20s–40s), polyarticular, severe radiographic chondrocalcinosis

— Counsel on family screening — first-degree relatives may benefit from baseline imaging if symptomatic

— Risk of flares spikes in first 2–6 weeks after surgery (rapid calcium shifts)

— Pre-treat with colchicine 0.6 mg daily for 4–6 weeks perioperatively if known CPPD

— Counsel patient on flare recognition

— Hold IV bisphosphonates if recent CPPD flare association

— Continue maintenance colchicine through admission unless contraindicated

— Replete magnesium proactively

Key distinction: A 35-year-old with bilateral knee chondrocalcinosis and elevated transferrin saturation has hereditary hemochromatosis, not idiopathic CPPD — order HFE genotype, refer hepatology, initiate therapeutic phlebotomy. The arthropathy itself does not regress with iron removal but liver/cardiac outcomes do.

Pregnancy:

Pediatrics:

Familial CPPD:

Post-parathyroidectomy patient:

Hospitalized/perioperative adults:

Complications and Adverse Outcomes

— Progressive cartilage destruction → secondary osteoarthritis, often with atypical distribution

— Severe destructive arthropathy ("pseudoneuropathic") at shoulder, knee, hip — radiographically resembles Charcot joint

— Tendon involvement: Achilles, supraspinatus, triceps — calcific tendinitis, rupture

— Ligamentous calcification — spinal stenosis, ligamentum flavum involvement

— Crowned dens syndrome — acute severe neck pain, fever, raised CRP; can mimic meningitis or GCA

— Cervical myelopathy from ligamentum flavum CPPD deposition

— Lumbar spinal stenosis from facet/ligamentous involvement

— Recurrent flares cause cumulative disability, deconditioning, falls, depression

— Chronic inflammation contributes to anemia of inflammation

— NSAID: GI bleed, AKI, HF exacerbation, hypertension

— Colchicine toxicity: diarrhea (early), myopathy, neuropathy, bone marrow suppression (delayed, especially with renal impairment or drug interactions)

— Steroid: hyperglycemia, infection, osteoporosis, adrenal suppression with repeated bursts, post-injection flare

— Repeated intra-articular steroids: cartilage thinning, tendon weakening

— Missed septic arthritis in a patient labeled as "pseudogout flare" — mortality up to 10–15%

— Missed crowned dens syndrome leading to empiric antibiotics for "meningitis" and lumbar puncture risk

— Failure to identify treatable secondary cause (hemochromatosis, hyperparathyroidism) → progressive organ damage

— Older adults with recurrent knee flares have measurably higher fall risk, ED visits, and 30-day readmission rates

Board pearl: Pseudo-neuropathic arthropathy of the knee or shoulder in an elderly patient without diabetes or syphilis should prompt evaluation for destructive CPPD arthropathy — order plain radiographs, look for chondrocalcinosis, fragmentation, and intra-articular debris.

Joint-related complications:

Spinal complications:

Systemic/inflammatory:

Treatment-related:

Diagnostic missteps:

Functional outcomes:

Communicate risk of recurrence at every visit — drives shared decisions about prophylaxis.

When to Escalate — Consult, ICU, or Inpatient Triage

— Uncomplicated acute mono/oligoarticular flare, hemodynamically stable, no septic concerns

— Reliable patient with access to follow-up within 1–2 weeks

— Atraumatic monoarthritis with inability to aspirate in clinic

— Failure of first-line therapy at 48–72 hours

— Polyarticular flare in a frail patient

— Septic arthritis cannot be excluded clinically (fever, immunocompromise, prosthetic joint, bacteremia) → admit for IV antibiotics and orthopedic washout pending cultures

— Crowned dens syndrome requiring IV therapy and imaging

— Inability to ambulate safely

— Comorbidity decompensation (HF, AKI, hyperglycemia) from flare or therapy

— Suspected colchicine toxicity (pancytopenia, rhabdomyolysis, severe diarrhea with electrolyte derangement)

— Severe colchicine overdose — multiorgan failure, requires supportive care, no antidote

— Septic shock from missed septic arthritis

— Crowned dens syndrome with airway/respiratory compromise (very rare)

— Rheumatology: refractory disease, chronic inflammatory phenotype, diagnostic uncertainty, immunomodulator initiation

— Orthopedics: prosthetic joint involvement, destructive arthropathy, suspected septic joint requiring washout

— Endocrinology: secondary causes — hyperparathyroidism, hemochromatosis (hepatology), hypomagnesemia evaluation

— Infectious disease: prosthetic joint infection workup

— Neurology/neurosurgery: cervical myelopathy from CPPD

CCS pearl: For an admitted patient with hot knee + fever + WBC 15,000, your order set is: NPO if surgery possible, IV fluids, arthrocentesis STAT, blood cultures × 2, empiric vancomycin + ceftriaxone, hold until Gram stain and crystal analysis result, ortho consult. De-escalate antibiotics once cultures negative at 48 hours and crystals confirmed.

Outpatient management appropriate for:

Same-day rheumatology or ED referral:

Admit to medicine when:

ICU consideration:

Specialty consults:

Document handoff clearly during transitions of care — incomplete sign-out is a frequent Step 3 patient-safety trap.

Key Differentials — Same-Category Causes (Other Crystal/Inflammatory Arthritides)

— Middle-aged men, postmenopausal women, CKD, diuretic use

— 1st MTP (podagra), midfoot, ankle, knee

— Tophi at helix, olecranon bursa, Achilles

— Negatively birefringent, needle-shaped crystals

— Hyperuricemia (often, not always during flare)

— Treat with NSAIDs/colchicine/steroids acutely; ULT (allopurinol, febuxostat) chronically

— Milwaukee shoulder: destructive shoulder arthropathy in elderly women, large bloody effusion, rotator cuff destruction

— Calcific tendinitis (supraspinatus most common) — radiographic calcific deposits

— Crystals not seen on standard polarized light — require Alizarin red stain

— End-stage renal disease, primary hyperoxaluria

— Bipyramidal birefringent crystals

— Fever, single hot joint, WBC often >50,000 (but overlaps), positive Gram stain/culture

— S. aureus most common; Neisseria in young sexually active adults

— Must be excluded in every acute monoarthritis

— Younger patient, recent GU/GI infection, asymmetric lower-extremity oligoarthritis, enthesitis, dactylitis

— Symmetric small-joint polyarthritis, prolonged morning stiffness, RF/anti-CCP positive, erosive on imaging

— Chronic CPP inflammatory arthritis mimics RA but serologies negative and chondrocalcinosis present

Key distinction: A bloody, large shoulder effusion with rotator cuff destruction in an elderly woman → Milwaukee shoulder (BCP/hydroxyapatite), not CPPD. Crystals require Alizarin red staining; treatment is conservative — joint protection, intra-articular steroids, and physical therapy; arthroplasty if disabling.

Gout (monosodium urate arthropathy):

Basic calcium phosphate (hydroxyapatite) disease:

Calcium oxalate arthropathy:

Septic arthritis:

Reactive arthritis / spondyloarthritis:

Rheumatoid arthritis:

Always send fluid for crystals and culture — they are not mutually exclusive findings.

Key Differentials — Other-Category Causes

— Lymphangitic streaking, demarcated erythema, lack of joint effusion or pain on passive ROM

— Aspiration of joint is safe through uninvolved skin if needed

— Swelling confined to bursa, full passive ROM of underlying joint preserved

— Septic bursitis common — aspirate and culture

— Anticoagulation, trauma, hemophilia

— Bloody aspirate without fat globules; consider intra-articular fracture if fat present

— Slower onset, mechanical pain pattern, less inflammation, mild effusion

— Synovial fluid WBC typically <2000

— Endemic area exposure, knee monoarthritis, oligoarticular, large painless effusion, intermittent

— Lyme serology positive, PCR of synovial fluid confirmatory

— Diabetes, syphilis, syringomyelia

— Painless deformity, midfoot collapse (rocker-bottom)

— Distinguish from pseudo-neuropathic destructive CPPD by sensory exam and underlying disease

— Bilateral shoulder/hip girdle stiffness, elevated ESR/CRP, age >50

— Crowned dens syndrome can mimic — check cervical CT before committing to high-dose steroids for GCA

— 2nd/3rd MCP involvement with hook osteophytes, chondrocalcinosis

— Elevated ferritin and transferrin saturation

Board pearl: A patient over 50 with sudden severe neck pain, fever, and elevated CRP — before diagnosing meningitis or giant cell arteritis, obtain a cervical spine CT to evaluate for crowned dens syndrome, which responds to NSAIDs/colchicine, not antibiotics or high-dose steroids.

Cellulitis overlying a joint:

Bursitis (prepatellar, olecranon):

Hemarthrosis:

Osteoarthritis flare:

Lyme arthritis:

Reactive arthritis post-Chlamydia, Salmonella, Shigella, Campylobacter, Yersinia

Charcot (neuropathic) arthropathy:

Polymyalgia rheumatica/GCA:

Hemochromatosis arthropathy:

Wilson disease arthropathy: rare; ceruloplasmin low, urinary copper elevated

Differential drives test choice — anchor each differential to one discriminating test.

Secondary Prevention and Long-Term Plan

— Colchicine 0.6 mg PO daily or BID — reduces flare frequency ~40–50%

— Low-dose NSAID daily (naproxen 250–500 mg) with PPI cover — alternative in colchicine-intolerant younger patients with preserved renal function

— Low-dose prednisone ≤5 mg daily — last resort due to systemic toxicity

— Methotrexate or hydroxychloroquine for refractory chronic inflammatory disease (rheumatology-led)

— Hyperparathyroidism → parathyroidectomy (with peri-op colchicine prophylaxis)

— Hemochromatosis → therapeutic phlebotomy to target ferritin <50 ng/mL

— Hypomagnesemia → oral magnesium oxide/glycinate; address causative meds (PPI, loop diuretics)

— Hypothyroidism → levothyroxine to euthyroid

— Hypophosphatasia → endocrinology; asfotase alfa for severe forms

— Weight reduction if BMI >25 — every kilogram reduces knee loading 3–4 kg

— Physical therapy for quadriceps strengthening, ROM, proprioception

— Footwear, knee unloader brace if varus OA pattern

— Acetaminophen, topical NSAIDs (diclofenac gel) preferred in elderly

— Duloxetine for chronic pain with mood overlap

— Intra-articular corticosteroid or hyaluronate as adjunct (note: hyaluronate can rarely trigger CPPD flare)

— Pneumococcal, influenza, COVID-19, shingles per age

— DEXA every 2 years if on chronic steroids; calcium/vitamin D supplementation

— Bisphosphonates if osteoporosis — counsel that IV bisphosphonate may trigger flare; consider oral or pre-treat with colchicine

Step 3 management: A 70-year-old with 4 knee flares this year on no prophylaxis, eGFR 55, no GI bleed history → start colchicine 0.6 mg daily with annual CBC/CMP monitoring, screen for secondary causes, refer PT, and arrange 3-month follow-up.

Flare prophylaxis (recurrent CPPD ≥3 flares/year or chronic inflammatory phenotype):

Treat underlying secondary causes:

Joint preservation:

Coexisting OA management:

Vaccinations and bone health:

Update problem list and reconcile medications at every visit.

Follow-Up, Monitoring, and Counseling

— Phone or telehealth check at 48–72 hours to confirm response

— In-person follow-up at 1–2 weeks to reassess function, taper therapy, review labs if started

— 3-month visit to evaluate prophylaxis decision and secondary cause workup

— Annual visit thereafter if stable

— On colchicine: CBC, CMP, CK annually (more often if symptoms, renal change, or new interacting drugs)

— On NSAIDs: BP, renal function, hemoglobin, GI symptoms every 3–6 months

— On chronic steroids: glucose, BP, weight, DEXA every 2 years, vaccination status

— On methotrexate: CBC, LFTs, creatinine every 4–8 weeks initially then every 3 months

— Iron studies and ferritin if hemochromatosis being treated by phlebotomy

— Early flare recognition and self-initiated colchicine/NSAID "pill in pocket" if previously prescribed

— Magnesium-rich diet (leafy greens, nuts, whole grains)

— Avoid known triggers: dehydration, post-op periods unrepleted, sudden calcium shifts

— Adequate hydration, weight management, sleep, smoking cessation

— Joint protection education with PT/OT

— Quadriceps strengthening for knee involvement

— Wrist splinting and adaptive equipment for hand CPPD

— Fall-prevention program if recurrent lower-extremity flares

— Driving safety after acute flare resolution

— Communicate with surgeons preoperatively (parathyroid, orthopedic, abdominal) about flare risk

— Pharmacy coordination for colchicine interactions

— Update advance directives in frail elderly

CCS pearl: At every Step 3 follow-up visit for a chronic condition, the high-yield orders are: medication reconciliation, age-appropriate cancer screening (USPSTF), immunizations, smoking cessation, alcohol screening, and depression screening (PHQ-2/9) — these score regardless of the index diagnosis.

Post-flare follow-up cadence:

Monitoring parameters:

Patient counseling:

Functional and rehab considerations:

Care coordination:

Document return precautions: fever, joint redness, inability to bear weight, or new neurologic symptoms.

Ethical, Legal, and Patient Safety Considerations

— Document risks (infection <1%, bleeding, post-injection flare 1–2%, skin atrophy, tendon weakening with repetition), benefits, and alternatives

— Use a teach-back approach in elderly with cognitive impairment; involve healthcare proxy when capacity is borderline

— Capacity is decision-specific — a patient with mild dementia may still consent to a routine knee aspiration

— Colchicine + CYP3A4/P-gp inhibitors (clarithromycin, diltiazem, verapamil, ritonavir, cyclosporine, strong statins) → potentially fatal toxicity. Always reconcile and use ePrescribing decision support.

— NSAID + ACEi/ARB + diuretic ("triple whammy") in elderly → AKI risk

— NSAID + anticoagulant → bleeding

— Reconcile at every transition of care; medication-error rates are highest at hospital discharge

— A patient discharged on a steroid taper without primary care follow-up within 1–2 weeks is a high-risk handoff; arrange follow-up before discharge

— Communicate any incidental chondrocalcinosis noted during inpatient imaging to the PCP for outpatient evaluation

— After an acute knee flare, assess gait, transfers, and reaction time before clearing for driving

— Document fall-prevention counseling — failure is a malpractice exposure

— Anchoring bias: a "known pseudogout patient" with a hot joint and fever still needs septic arthritis evaluation

— Document differential consideration and arthrocentesis offer/decline

— Cost-conscious prescribing: generic colchicine, intra-articular triamcinolone is inexpensive and effective; anakinra is costly — use stepwise

— Insurance prior authorization for biologics — document prior-therapy failures

— Suspected elder abuse if injury patterns inconsistent with the reported mechanism in an elderly fall patient — mandatory reporting to Adult Protective Services in all US states

Step 3 management: Before discharging an 82-year-old after an inpatient pseudogout flare, ensure: medication reconciliation, follow-up scheduled in 1–2 weeks, written instructions in patient's language at 6th-grade reading level, contact number for after-hours questions, and fall-risk counseling documented. This is the prototypical Step 3 safe-handoff bundle.

Informed consent for arthrocentesis and intra-articular injection:

Medication safety — the highest-yield patient-safety domain in CPPD:

Transition-of-care risk:

Falls and driving:

Diagnostic safety:

Health-systems issues:

Reporting:

High-Yield Associations and Rapid-Fire Facts

Board pearl: A 45-year-old man with knee chondrocalcinosis, skin hyperpigmentation, and diabetes → hereditary hemochromatosis — order transferrin saturation and ferritin, then HFE gene testing. The arthropathy is often the presenting feature.

Crystal morphology: CPP = rhomboid, positively birefringent (blue when parallel); MSU = needle, negatively birefringent (yellow when parallel). Mnemonic: "Parallel Blue Positive Pseudogout."

Joints favored: knee > wrist > MCP > hip > shoulder > elbow > ankle. Gout favors 1st MTP, midfoot, ankle, knee.

Triggers: surgery, trauma, severe illness, IV bisphosphonate, intra-articular hyaluronate, rapid changes in serum calcium (post-parathyroidectomy).

Secondary causes — the "4 H's": Hyperparathyroidism, Hemochromatosis, Hypophosphatasia, Hypomagnesemia (plus hypothyroidism, Wilson, Gitelman/Bartter).

Radiographic chondrocalcinosis sites: knee menisci, triangular fibrocartilage of wrist, symphysis pubis, glenoid labrum, acetabulum, intervertebral disc.

Hand X-ray clue: hook-like osteophytes at 2nd and 3rd MCPs — think hemochromatosis with CPPD.

Wrist X-ray clue: scapholunate dissociation, SLAC wrist arthritis.

Crowned dens syndrome: acute neck pain + fever + elevated CRP in elderly → CT shows calcification around odontoid; treat with NSAID/colchicine/steroid, not antibiotics.

Milwaukee shoulder: BCP/hydroxyapatite, not CPPD — elderly women, bloody effusion, RC tear.

First-line treatment in elderly: intra-articular triamcinolone after arthrocentesis excludes infection.

First-line prophylaxis: low-dose colchicine 0.6 mg daily.

Colchicine toxicity triad: GI upset → cytopenias → neuromyopathy.

Drug interaction: colchicine + clarithromycin/diltiazem/statin in CKD → fatal.

Pregnancy/pediatric CPPD: assume secondary cause until proven otherwise.

Post-parathyroidectomy flare: pre-treat with colchicine 4–6 weeks.

Asymptomatic chondrocalcinosis: no treatment; treat underlying metabolic disease.

ACR/EULAR 2023: renamed "pseudogout" → "acute CPP crystal arthritis."

Pattern-match rapidly: age + joint + radiograph + secondary clue.

Board Question Stem Patterns

— 78-year-old woman, day 3 post-hip arthroplasty, develops hot swollen knee, T 38.2°C, WBC 12,000. Aspirate shows 25,000 WBC, rhomboid weakly positively birefringent crystals, negative Gram stain. Answer: intra-articular triamcinolone after culture sent; supportive care.

— 72-year-old with CKD stage 3 on chronic colchicine for pseudogout prophylaxis is prescribed clarithromycin for pneumonia; presents 5 days later with diarrhea, myalgias, pancytopenia. Answer: colchicine toxicity from CYP3A4/P-gp inhibition; stop colchicine, supportive care, switch antibiotic to azithromycin.

— 42-year-old man with recurrent wrist and knee arthritis, X-ray shows chondrocalcinosis, MCP hook osteophytes, hepatomegaly, elevated AST/ALT. Answer: hereditary hemochromatosis; check transferrin saturation and ferritin, HFE genotype, therapeutic phlebotomy.

— 76-year-old presents with severe acute neck pain, low-grade fever, CRP 80, neck rigidity, no headache or photophobia. CT cervical spine shows calcification around odontoid. Answer: crowned dens syndrome — NSAID or short steroid course; not antibiotics or LP.

— Acute knee swelling in 80-year-old; synovial fluid shows weakly positively birefringent rhomboid crystals; uric acid normal. Answer: pseudogout, not gout — no ULT needed.

— Known pseudogout patient with hot knee and fever; the next best step is arthrocentesis with Gram stain and culture before starting steroids — anchoring bias kills.

— Post-injection pain peaking at 24 hours, no fever, sterile aspirate → post-injection steroid flare; treat with ice/NSAID, reassure.

— Knee X-ray for unrelated trauma shows chondrocalcinosis; patient asymptomatic. Answer: no treatment; screen for secondary causes if young.

Key distinction: Step 3 vignettes frequently test the transition decision — "what is the next best step in the outpatient management?" — favoring prophylactic colchicine for recurrent flares and referral for secondary cause workup over acute pharmacology.

Classic acute flare stem:

Drug-interaction stem:

Secondary cause stem (young patient):

Crowned dens stem:

Differential from gout stem:

Septic arthritis exclusion stem:

Procedure complication stem:

Asymptomatic chondrocalcinosis stem:

Read the last sentence first — it tells you whether the question wants diagnosis, acute therapy, prophylaxis, or referral.

One-Line Recap

Pseudogout (CPPD) is a crystal arthropathy of older adults diagnosed by rhomboid, weakly positively birefringent calcium pyrophosphate crystals on synovial fluid analysis, managed acutely with arthrocentesis plus intra-articular or systemic anti-inflammatories, and longitudinally with colchicine prophylaxis and evaluation for treatable secondary causes — always excluding septic arthritis first.

High-yield recap bullets:

Board pearl: "Parallel, Blue, Positive = Pseudogout" — the single mnemonic that distinguishes CPPD from gout on polarized microscopy, and the single most testable fact in this topic across both Step 2 CK and Step 3.

Diagnosis: arthrocentesis with polarized light microscopy is the gold standard; radiographic chondrocalcinosis (knee menisci, TFCC, symphysis) is supportive but not sensitive enough to exclude disease.

Acute therapy: intra-articular corticosteroid is first-line in elderly/multimorbid; NSAIDs and colchicine for younger healthier patients; oral/IM steroids for polyarticular flares. Anakinra for refractory hospitalized cases.

Secondary causes ("4 H's"): hyperparathyroidism, hemochromatosis, hypophosphatasia, hypomagnesemia — mandatory workup in any patient under 55 or with atypical features; treating the underlying disease prevents progression but does not reverse established chondrocalcinosis.

Prophylaxis: low-dose colchicine 0.6 mg daily for recurrent flares; renally dose-adjust and screen for CYP3A4/P-gp interactions (clarithromycin, diltiazem) that cause fatal toxicity.

Patient safety: never anchor — a hot joint in a "known pseudogout patient" still requires arthrocentesis to exclude septic arthritis; reconcile medications at every transition of care; arrange follow-up within 1–2 weeks after any flare.

Special phenotypes: crowned dens syndrome (acute neck pain + fever in elderly) responds to NSAIDs/steroids; Milwaukee shoulder is BCP, not CPPD; pseudo-RA pattern is RF/CCP-negative.